Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Prevention of Chronic Neuropathic Pain After Spinal Cord Trauma
NCT03255330Phase 3Withdrawn
- Sponsor
- Masaryk University
- Start
- Oct 2017
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 3, randomised trial of gabapentin in chronic neuropathic pain (2 arms), sponsored by Masaryk University. Primary endpoint: Analgesic effect of gabapentin at 3 months. Planned start Oct 2017; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT03255330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255330.